Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.

Sarkar K, Weinberg CR, Oddis CV, Medsger TA Jr, Plotz PH, Reveille JD, Arnett FC, Targoff IN, Genth E, Love LA, Miller FW.

Arthritis Rheum. 2005 Aug;52(8):2433-8.

2.

[Autoantibodies specifically detected in patients with polymyositis/dermatomyositis].

Sato S.

Nihon Rinsho Meneki Gakkai Kaishi. 2006 Apr;29(2):85-93. Review. Japanese.

3.
4.

[Myositis-specific autoantibodies and their clinical significance].

Suzuki S.

Brain Nerve. 2011 Nov;63(11):1197-203. Review. Japanese.

PMID:
22068472
5.

Immune manifestations of inflammatory muscle disease.

Targoff IN.

Rheum Dis Clin North Am. 1994 Nov;20(4):857-80. Review.

PMID:
7855326
6.

Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria.

Mastaglia FL, Phillips BA.

Rheum Dis Clin North Am. 2002 Nov;28(4):723-41. Review.

PMID:
12510664
7.

Humoral immunity in polymyositis/dermatomyositis.

Targoff IN.

J Invest Dermatol. 1993 Jan;100(1):116S-123S. Review.

PMID:
8423380
8.
9.

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.

Mammen AL.

Ann N Y Acad Sci. 2010 Jan;1184:134-53. doi: 10.1111/j.1749-6632.2009.05119.x. Review.

PMID:
20146695
10.

Idiopathic inflammatory myopathy: autoantibody update.

Targoff IN.

Curr Rheumatol Rep. 2002 Oct;4(5):434-41. Review.

PMID:
12217249
11.

[Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].

Eymard B.

Presse Med. 2003 Oct 25;32(35):1656-67. Review. French.

PMID:
14631270
12.

Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.

Gherardi RK.

Presse Med. 2011 Apr;40(4 Pt 2):e209-18. doi: 10.1016/j.lpm.2010.12.013. Review.

PMID:
21376512
13.

The geoepidemiology of autoimmune muscle disease.

Prieto S, Grau JM.

Autoimmun Rev. 2010 Mar;9(5):A330-4. doi: 10.1016/j.autrev.2009.11.006. Review.

PMID:
19906360
14.

Update on idiopathic inflammatory myopathies.

Briani C, Doria A, Sarzi-Puttini P, Dalakas MC.

Autoimmunity. 2006 May;39(3):161-70. Review.

PMID:
16769649
15.

[Myositis-specific autoantibodies].

Gran JT, Molberg Ø, Dobloug GC, Andersson H, Taraldsrud E, Scheie D.

Tidsskr Nor Laegeforen. 2009 Aug 27;129(16):1631-4. doi: 10.4045/tidsskr.09.35501. Review. Norwegian.

16.

Autoantibodies in polymyositis and dermatomyositis.

Ghirardello A, Bassi N, Palma L, Borella E, Domeneghetti M, Punzi L, Doria A.

Curr Rheumatol Rep. 2013 Jun;15(6):335. doi: 10.1007/s11926-013-0335-1. Review.

PMID:
23591825
17.

Polymyositis-dermatomyositis and infections.

Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F, Arienti S, Todesco S, Doria A.

Autoimmunity. 2006 May;39(3):191-6. Review.

PMID:
16769652
18.

Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.

Venalis P, Lundberg IE.

Rheumatology (Oxford). 2014 Mar;53(3):397-405. doi: 10.1093/rheumatology/ket279. Review.

19.

The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.

Tansley S, Gunawardena H.

Clin Rev Allergy Immunol. 2014 Dec;47(3):264-73. doi: 10.1007/s12016-013-8387-6. Review.

PMID:
24048686
20.

Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies.

Miller FW.

Curr Opin Rheumatol. 1991 Dec;3(6):902-10. Review.

PMID:
1772743
Items per page

Supplemental Content

Support Center